These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 35851862)
1. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies. Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862 [TBL] [Abstract][Full Text] [Related]
2. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues. Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451 [TBL] [Abstract][Full Text] [Related]
3. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing. Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073 [TBL] [Abstract][Full Text] [Related]
4. Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine. Seidlitz T; Koo BK; Stange DE Cell Death Differ; 2021 Jan; 28(1):68-83. PubMed ID: 33223522 [TBL] [Abstract][Full Text] [Related]
5. Clinical value and influencing factors of establishing stomach cancer organoids by endoscopic biopsy. Li J; Chen Y; Zhang Y; Peng X; Wu M; Chen L; Zhan X J Cancer Res Clin Oncol; 2023 Jul; 149(7):3803-3810. PubMed ID: 35987927 [TBL] [Abstract][Full Text] [Related]
6. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine. Pamarthy S; Sabaawy HE Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953 [TBL] [Abstract][Full Text] [Related]
7. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application. Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861 [TBL] [Abstract][Full Text] [Related]
9. Gastric cancer patient-derived organoids model for the therapeutic drug screening. Xu J; Gong J; Li M; Kang Y; Ma J; Wang X; Liang X; Qi X; Yu B; Yang J Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130566. PubMed ID: 38244703 [TBL] [Abstract][Full Text] [Related]
10. Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy. Yoon C; Lu J; Kim BJ; Cho SJ; Kim JH; Moy RH; Ryeom SW; Yoon SS J Gastrointest Surg; 2023 Apr; 27(4):666-676. PubMed ID: 36627466 [TBL] [Abstract][Full Text] [Related]
11. Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients. Wu H; Wang W; Zhang Y; Chen Y; Shan C; Li J; Jia Y; Li C; Du C; Cai Y; Zhang Y; Zhang S; Wu F Int J Cancer; 2024 Jul; 155(2):324-338. PubMed ID: 38533706 [TBL] [Abstract][Full Text] [Related]
12. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer. Zhao Y; Li S; Zhu L; Huang M; Xie Y; Song X; Chen Z; Lau HC; Sung JJ; Xu L; Yu J; Li X Cell Rep Med; 2024 Jul; 5(7):101627. PubMed ID: 38964315 [TBL] [Abstract][Full Text] [Related]
13. Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response. Seppälä TT; Zimmerman JW; Suri R; Zlomke H; Ivey GD; Szabolcs A; Shubert CR; Cameron JL; Burns WR; Lafaro KJ; He J; Wolfgang CL; Zou YS; Zheng L; Tuveson DA; Eshlemann JR; Ryan DP; Kimmelman AC; Hong TS; Ting DT; Jaffee EM; Burkhart RA Clin Cancer Res; 2022 Aug; 28(15):3296-3307. PubMed ID: 35363262 [TBL] [Abstract][Full Text] [Related]
14. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients. Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046 [TBL] [Abstract][Full Text] [Related]
15. Preclinical investigation of patient-derived cervical cancer organoids for precision medicine. Seol HS; Oh JH; Choi E; Kim S; Kim H; Nam EJ J Gynecol Oncol; 2023 May; 34(3):e35. PubMed ID: 36659831 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids. Chen H; Yang Y; Shi J; Yan T; Wang J; Yang Y; Lu Q; Feng H; Du J; Cao Z; Weygant N Curr Cancer Drug Targets; 2024; 24(5):546-555. PubMed ID: 37997804 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids. de Kort WWB; Millen R; Driehuis E; Devriese LA; van Es RJJ; Willems SM Head Neck Pathol; 2024 Jun; 18(1):59. PubMed ID: 38940869 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine. Taverna JA; Hung CN; Williams M; Williams R; Chen M; Kamali S; Sambandam V; Hsiang-Ling Chiu C; Osmulski PA; Gaczynska ME; DeArmond DT; Gaspard C; Mancini M; Kusi M; Pandya AN; Song L; Jin L; Schiavini P; Chen CL Lung Cancer; 2024 Apr; 190():107533. PubMed ID: 38520909 [TBL] [Abstract][Full Text] [Related]
19. Establishment and Characterization of Patient-derived Gastric Organoids from Biopsies of Benign Gastric Body and Antral Epithelium. Buckley KH; Beyries KA; Ryeom S; Yoon SS; Katona BW J Vis Exp; 2024 Jan; (203):. PubMed ID: 38345211 [TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening. Yang Z; Yu J; Wong CC Cells; 2024 Aug; 13(16):. PubMed ID: 39195202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]